Industry News

Oct 10, 2018
By Pharmaceutical Technology Editors
This year’s awards attracted more than 250 entries, which included innovations in products and service offerings from across the bio/pharmaceutical supply chain and honored companies and individuals driving the industry forward.
Oct 05, 2018
By Pharmaceutical Technology Editors
The new bioLIVE event, launching this year with CPhI Worldwide 2018, will explore innovation in bioprocessing and manufacturing with a focus on the roles of innovative methods and technology for biopharma continuous manufacturing.
Oct 05, 2018
By Pharmaceutical Technology Editors
Advances in biologic drug development require increased methodological and technological innovation from the biopharma industry. Learn more at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Oct 05, 2018
By Pharmaceutical Technology Editors
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation to seek views on how legislations and procedures of the agency may need to be modified should there be a ‘no-deal’ Brexit scenario.
Oct 01, 2018
FDA is joining with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to support innovation in antimicrobials.
Oct 01, 2018
By Pharmaceutical Technology Editors
Researchers who are younger than 35 years with an advanced degree and working within Europe will be able to apply for the award.
Sep 28, 2018
By Pharmaceutical Technology Editors
The agency sent a warning letter to the Indian company after an inspection found CGMP violations that included a lack of written procedures and analytical testing.
Sep 28, 2018
By Pharmaceutical Technology Editors
CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years.
Sep 27, 2018
By Pharmaceutical Technology Editors
The agency has entered into an agreement with the National Academies of Science, Engineering & Medicine and has expanded agreements with the University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation to conduct research on the compounding of drugs.
Sep 27, 2018
By Pharmaceutical Technology Editors
The agency announced that differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
native1_300x100
lorem ipsum